Skip to main content
. 2022 Aug 3;2022(8):CD015270. doi: 10.1002/14651858.CD015270

NCT04939506.

Study name COVID‐19 vaccine education at the point of testing to increase vaccine uptake in vulnerable communities in SE Louisiana
Starting date 25 June, 2021
Contact information Sara Al‐Dahir, PharmD 5045205766 saaldah@xula.edu 
Methods 
  • Study design: randomised controlled trial

  • Type of publication: trial registration

  • Setting: vulnerable communities in the Southeastern Louisiana region

  • Country: USA

  • Language: NR

Intervention Rapid education
  • Behavioral: COVID‐19 Vaccine Education at the Point of COVID‐19 Testing

Population 
  • Population: unvaccinated adults

  • Inclusion criteria: 18 to 99 years, unvaccinated, vulnerable communities in the Southeastern Louisiana region

  • Exclusion criteria: NR

Outcomes Primary outcome
  • Vaccine uptake (COVID‐19 Vaccine completion)


Secondary outcome
  • Vaccine hesitancy (Vaccine Hesitancy Likelihood Scale)

Estimated completion date and number of participants June 2023, 375 planned
Notes
  • COI: NR

  • Funding: Xavier University of Louisiana